Argenx is a biopharmaceutical company based in Boston, MA, specializing in the development of innovative antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
With a focus on cutting-edge research and a commitment to improving patient outcomes, Argenx aims to bring novel treatment options to those in need through its dedication to scientific excellence and collaboration with healthcare partners.
Generated from their business information